79.9%
antimigraine therapiesmigraineanti-CGRP mAbsanti-CGRP monoclonal antibodies
…migraine pathophysiology. It led to the development of specific antimigraine therapies (anti-CGRP monoclonal antibodies (anti-CGRP mAbs)), but challen…
1articles mentioning treatments
1treatment mentions
1distinct treatments extracted
0%of mentions human-reviewed
Active filtersEntity: antimigraine therapies ×
antimigraine therapies
This treatment is selected. Its supporting articles are shown below.